AIM: To clarify the mechanism by which insulin resistance develops in obesity, Zucker fatty rats (ZFR) and lean litter mates (ZLR) were temporally subjected to oral glucose tolerance tests (OGTT) at 6 and 15 weeks of age. METHOD: As candidates for causative factors of insulin resistance, plasma leptin, free fatty acids (FFA) and tumor necrosis factor (TNF)-a levels were evaluated. RESULTS: There was no difference in the body weight between the two groups at 6 weeks of age, but ZFR were significantly heavier than ZLR at 15 weeks of age. At 6 weeks of age, blood glucose levels and area under the curve of glucose (AUCg) during OGTT were not significantly different between the two groups, while plasma insulin levels and area under the curve of insulin (AUCi) in the ZFR group were significantly higher than those in the ZLR group. At 15 weeks of age, the blood glucose levels and AUCg as well as plasma insulin levels and AUCi in the ZFR group during OGTT were significantly higher than those in the ZLR group. The ratio of fasting insulin to glucose in the ZFR group was significantly higher than that in the ZLR group at 6 and 15 weeks of age. Peripheral and portal plasma leptin and FFA levels were significantly higher in ZFR than ZLR both at 6 weeks and 15 weeks of age. Meanwhile, at 6 weeks, plasma TNF-a levels and expression of TNF-a protein in subcutaneous and visceral fat tissues were similar in both groups; however at 15 weeks, these were significantly higher in the ZFR group than the ZLR group. CONCLUSION: These results suggest that FFA rather than TNF-a may play an important role in early events involved in the development of insulin resistance and TNF-a accelerates insulin resistance together with FFA in the later stage.
Introduction
The Zucker fatty (fa=fa) rat (ZFR) is genetically homozygous for a mutation in the leptin receptor gene 1 and develops pronounced hyperinsulinemia and severe obesity with relatively mild hyperglycemia. 2 The ZFR is widely used as a model for type 2 diabetes. Its metabolic syndrome is the combined result of the leptin-receptor defect, the hyperphagia, and secondary endocrine abnormalities. The discovery of the ob gene 3 and analysis of the biology of its gene product, leptin, reveal that leptin is an adipocyte-derived satiety factor which is involved in the regulation of food intake and energy expenditure. Leptin is expressed abundantly in the adipose tissue, 3 also in the hypothalamus and peripheral tissues, 4 and secreted into the circulation. 5 Except for the leptin-deficient ob=ob mouse, leptin mRNA levels as well as serum protein levels are increased (leptin-resistance) in all animal models of obesity, regardless of whether the obesity is caused by either genetic defects, hypothalamic lesions, or brown adipose tissue deficiency.
Recently, it has been suggested that physiologically active substances produced by adipose tissues, such as tumor necrosis factor-a (TNF-a) and free fatty acids (FFA), play a major role in the development of insulin resistance in obesity. 7 TNF-a is one of the mediators involved in lipid metabolism 8 and in vivo insulin sensitivity. 9 TNF-a is expressed in macrophages and adipocytes, and is substantially increased in obesity in both rodents 9 and humans. 10 Hotamisligil et al, 9 have shown that in vivo neutralization of TNF-a ameliorates insulin resistance in ZFR. In addition, administration of TNF-a to animals and humans results in reduced insulin sensitivity and causes insulin resistance.
Randle et al advocated the glucose-fatty acid cycle (Randle cycle) hypothesis that FFA competes with glucose for substrate oxidation in isolated rat muscle preparations and speculated that increased fat oxidation may cause the insulin resistance associated with diabetes and obesity. 12 Recently the effects of FFA on insulin secretion also have become the focus of extensive investigation. 13 Acutely, FFA stimulates glucose-induced insulin secretion both in vitro 14 and in vivo. 15 On the other hand, there are many studies on the chronic effects of FFA-induced insulin resistance. 16, 17 In the present study we investigated the sequence of events in the development of insulin resistance and overt diabetes in ZFR, and found that FFA rather than TNF-a seemed to play an important role in early stages of the development of insulin resistance in this animal model of obesity.
Materials and methods

Animals
Six-week-old or 15-week-old male ZFR and Zucker lean rat (ZLR) were housed in a humidity-and temperature-conditioned room with a 12 h-light=dark cycle. The rats were divided into two groups of five animals.
Methods
Consumed food was measured every 2 days, and the body weight of both groups was measured at 9 -11 o'clock every Monday morning. The rats were starved overnight (ca 20 h) before the experiment. Both groups of rats were administered glucose (2 g=kg) orally, through a tube inserted into the stomach. Blood samples for glucose and insulin measurements were obtained in an anesthetized state from the tail vein at 0, 30, 60 and 120 min after oral glucose load. The rats were starved overnight and killed under pentobarbital anesthesia (intra-peritoneal administration of 6 mg=100 g body weight of sodium pentobarbital) 1 week after the oral glucose tolerance test (OGTT) . To analyze the factor to produce the systemic and hepatic insulin resistance, the blood was collected from the peripheral and portal veins separately. The organs of pancreas, kidney, spleen, heart and liver were excised, and their wet weights of both groups were immediately measured in the fasting state. The visceral fat tissues were collected from the regions around the heart, the kidney, epididymis, mesenteries and dorsal peritoneum. Subcutaneous fat tissues were also excised from the interscapular, brachial, femoral, dorsal and abdominal subcutaneous regions. All fat tissues and organs were stored immediately in liquid nitrogen.
Insulin was measured by radioimmunoassay (RIA). 18 Blood glucose was measured using the glucose oxidase method. Calculation of the area under the curve of glucose (AUCg) and insulin (AUCi) were made with the trapezoidal method. 19 Using a specific antibody (anti-rat), plasma TNF-a was measured by enzyme-linked immunosorbent assay (ELISA) with a kit obtained from Kanto Reagents (Astem Forest, Japan). Plasma leptin was measured by ELISA (Immuno-Biological Laboratories Co. Ltd), and plasma FFA was measured by spectrophotometric assays using a commercially available kit obtained from Wako (Richmond, VA, USA).
Western blot analysis
The adipose tissue was prepared as described previously. 20 Adipose tissue (0.2 g) was homogenized in ice-cold buffer (50 mM HEPES, 150 mM sodium chloride, 1% Triton X-100 pH 7.8, 1 mM PMSF, 2.5 mg=ml pepstatin, 5 mg=ml leupeptin, and 10 mg=ml aprotinin), and the resulting homogenates were centrifuged for 20 min at 4 C at 15 300 g, aliquoted, and stored at 7 80 C until used. Samples containing 0.5 mg of protein were resolved by electrophoresis in a 12% SDSpolyacrylamide gel. Rat TNF-a (Pepro Tech Inc. Rocky Hill, NJ, USA) and Rainbow markers (Amersham, Piscataway, NJ, USA) were used as molecular markers. Proteins were transferred to polyvinylidene fluoride (PVDF, Millipore, Bedford, MA, USA) membranes. Blots were incubated with anti-mouse TNF-a polyclonal antibody (Endogen, Woburn, MA, USA) at 0.65 mg=ml in low-fat milk solution overnight at 4 C. After the membranes were incubated for 1 h at room temperature with horseradish peroxidase-conjugated donkey anti-rabbit IgG (0.2 mg=ml (1=5000), Amersham, Piscataway, NJ, USA) in TBST-BSA, they were then incubated with enhanced chemiluminescence (ECL) reagents (Amersham, Piscataway, NJ, USA) and exposed to X-ray film for 3 min. Densitometric analysis of immunoblots was performed using Adobe PhotoShop (Adobe Systems Inc, Japan) software for a Macintosh computer (Apple Computers Inc, Japan).
Statistical analysis
Data are shown as means AE s.e. Statistical analysis was performed by Student's unpaired t-test for unpaired means obtained from two groups. Comparisons between means in the one group were made using Student's paired t-test. A P-value of less than 0.05 was accepted as statistically significant.
Results
Body weight and food intake There was no difference in body weight between the 6-weekold ZFR and ZLR groups, but the body weight of the 15-weekold ZFR group was significantly increased compared with the ZLR group (Table 1) . Average food intake in the ZFR group was significantly higher than in the ZLR group at both 6 and 15 weeks of age (Table 1) .
Fasting blood glucose, fasting insulin and fasting insulin : glucose ratio At 6 weeks of age, there was no significant difference in fasting blood glucose levels between the ZFR and ZLR groups Early events in Zucker fatty rat R Liu et al ( Figure 1 ). Fasting blood glucose levels in the ZLR group did not change from 6 to 15 weeks, while those in the ZFR group increased and were significantly higher than those in ZLR at 15 weeks of age. Although fasting plasma insulin levels at 6 weeks of age in the ZFR group were higher than those in the ZLR group, there was no significant difference ( Figure 1 ). This may be due in part to the impaired insulin secretion by a long (ca 20 h) fast. 21 From 6 to 15 weeks fasting insulin levels did not change significantly in the ZLR group, but those in the ZFR group did increase and were significantly higher than those in ZLR at 15 weeks of age. The ratio of fasting insulin to glucose in the ZFR group was significantly higher than that in the ZLR group at 6 weeks (5. , P < 0.05) of age (Figure 1 ), respectively.
Oral glucose tolerance test
Blood glucose levels after glucose load were not significantly different at each time point between the two groups at 6 weeks of age, but at 15 weeks those from the ZFR group were significantly higher than those from the ZLR group at each corresponding time point (Figure 2 ). Plasma insulin levels at 6 weeks of age reached a peak value at 30 min in the ZFR group, which was significantly increased compared to the ZLR group (2.76 AE 0.72 vs 0.70 AE 0.16 ng=ml, P < 0.05). The plasma insulin levels in the ZFR group were significantly higher than those in the ZLR group at 15 weeks of age at 0, 30 and 60 min ( Figure 2) .
As for the AUCg, there was no significant difference between the two groups at 6 weeks of age. However, at 15 weeks of age, the AUCg of the ZFR group showed significant increase compared to that of the ZLR group during oral Note: data are the means AE s.e. for five rats. Significant by unpaired t-test, *P < 0.05, **P < 0.01, ***P < 0.001 vs ZLR. (Table 1) . On the other hand, the AUCi of the ZFR group was significantly increased compared to the ZLR group at both 6 and 15 weeks of age (Table 1) .
Wet weight of each visceral organ
The wet weight of liver in the ZFR group was significantly higher than that in the ZLR group at 6 and 15 weeks of age, but the wet weight of heart, spleen, pancreas and kidney was not significantly different between the two groups ( Table 2) .
Liver glycogen content
The glycogen content per 1 g of liver was significantly higher in the ZFR group than in the ZLR group at both 6 and 15 weeks of age ( Table 1 ). The glycogen content of liver significantly increased from 6 to 15 week in ZFR.
Plasma TNF-a, leptin and FFA Peripheral and portal plasma TNF-a levels did not significantly change from 6 to 15 weeks in the ZLR group, but both of them significantly increased from 6 to 15 weeks in the corresponding collection sites of the ZFR group (Table 3) . At 6 weeks of age, there was no significant difference in Figure 2 Plasma glucose and insulin levels in oral glucose tolerance test in the ZFR and ZLR groups at 6 and 15 weeks of age. Means AE s.e. (n ¼ 5) are shown. *P < 0.05, **P < 0.01 vs ZLR group by unpaired t-test. Early events in Zucker fatty rat R Liu et al peripheral or portal levels of TNF-a between the ZFR and ZLR groups. On the other hand, at 15 weeks of age, both peripheral and portal levels of TNF-a in the ZFR group were significantly higher compared to those in the ZLR group. Peripheral leptin levels significantly increased from 6 to 15 weeks in the ZFR group. Both peripheral and portal leptin levels significantly increased from 6 to 15 weeks in the ZLR group. Furthermore peripheral and portal leptin levels from ZFR were significantly higher compared to ZLR at 6 and 15 weeks of age. In addition, peripheral leptin levels were significantly higher than the portal levels in the ZFR group at 15 weeks of age. Portal FFA levels significantly increased from 6 to 15 weeks in ZLR. Both peripheral and portal FFA levels from the ZFR group were significantly higher compared to the ZLR group at both 6 and 15 weeks of age (Table 3) .
Expression of TNF-a protein
The expression levels of TNF-a protein in fat tissues were evaluated by Western blotting (Figures 3 and 4) . The TNF-a protein levels at 6 weeks of age in all subcutaneous fat ( Figures 3A and B ) and visceral fat ( Figure 4A and B) tissues were similar between both groups. The TNF-a protein levels at 15 weeks of age in all subcutaneous fat (dorsal, abdominal, interscapular, brachial and femoral) in the ZFR group were significantly higher than those in the ZLR group ( Figure 3C and D). On the other hand, the TNF-a protein levels in visceral fat tissues of heart, epididymal and dorsal peritoneal in the ZFR group were significantly higher than those in the ZLR group ( Figure 4C and D) .
Discussion
To clarify the mechanism underlying the onset of insulin resistance in obesity, we examined temporal change of adipocytokines and FFA as causative factors of insulin resistance, using ZFR as a model animal. ZFR develops obesity and diabetes because of a failure to respond to leptin 2 due to a mutation in the receptor gene that is expressed in the hypothalamus, 1 although ob gene expression and leptin secretion are markedly augmented (leptin resistance). 3, 6 Although our study showed that the hyperinsulinemia and hyperleptinemia in ZFR already existed at 6 weeks of age, the direct effects of leptin on insulin resistance have still been controversial. Recently, leptin has been reported to have antidiabetic effects in insulin-deficient diabetic rats 22 and lipoatrophic diabetic mice. 23 On the other hand, some contradictory reports demonstrated that leptin-impaired insulin action and led to insulin resistance. 5, 24 A recent study reported that leptin has additive effects with insulin in inhibiting phosphorylase and stimulating glycogen storage in hepatocytes, indicating that the primary action of leptin in hepatocytes is to enhance glycogen storage. 25 In the present study, the wet weight and the glycogen content of liver had already increased in the ZFR group at 6 weeks of age. Although increased mass of glycogen storage could be a factor contributing to glucose intolerance, 26 further studies are needed to clarify how much influence glycogen storage has on hepatic glucose release and glucose intolerance in these models.
Zucker et al 27 reported that a significant increase in serum insulin was evident in 3-week-old 'fatties' reaching a peak at 15 weeks of age. Etgen et al 28 reported that prior to 8 weeks of age, Zucker diabetic fatty rats clearly displayed peripheral (skeletal muscle) insulin resistance but maintained nearnormal glucose levels through a compensatory elevation in circulating insulin levels. In the present study, the AUCi and the ratio of fasting insulin to glucose in the ZFR group were significantly higher than those in the ZLR group at 6 weeks of age, however blood glucose levels and AUCg were not significantly different between the two groups. These results indicated that the hyperinsulinemia had already existed, but the hyperglycemia had not yet appeared in ZFR at 6 weeks of age.
There was no significant difference in body weight between the ZFR and ZLR groups at 6 weeks of age, while peripheral and portal plasma FFA is significantly higher in ZFR than in ZLR even in this age. Phillips et al reported that the size and number of adipocyte become greater in Zucker (fa=fa) rat pups than lean littermates at 17 days of age. 29 Further studies on the size and number of adipocyte or on Early events in Zucker fatty rat R Liu et al The signal intensity of the band was quantified using Adobe PhotoShop software, and the percentage ratio to the corresponding standard TNF-a was calculated as a TNF-a protein relative intensity. Means AE s.e. for five rats. *P < 0.05, **P < 0.01 vs the same adipose tissue in ZLR group by unpaired t-test.
Early events in Zucker fatty rat R Liu et al Figure 4 Western blotting for TNF-a in the visceral adipose tissues from the ZFR or ZLR groups at 6 weeks (A) and 15 weeks of age (C). TNF-a (0.1 mg) was applied as a molecular marker (lane 1) in (A) and (C). Lanes 2 -11, samples of the fat tissues. (B) and (D) Relative signal intensities of TNF-a protein in the Western blot are shown in the ZFR (black bars) and ZLR (white bars) groups. The signal intensity of the band was quantified using Adobe PhotoShop software, and the percentage ratio to the corresponding standard TNF-a was calculated as a TNF-a protein relative intensity. Means AE s.e. for five rats. *P < 0.05, **P < 0.01 vs the same adipose tissue in the ZLR group by unpaired t-test.
Early events in Zucker fatty rat R Liu et al activity of hormone-sensitive lipase (HSL) in adipose cells are needed 30 to clarify the mechanism by which plasma FFA increases in the early stage of obesity.
Contrary to the classical mechanism of FFA-induced insulin resistance as proposed by Randle et al 12 in which FFA exerts their effect through initial inhibition of pyruvate dehydrogenase, Roden et al found that elevation in plasma FFA concentration caused insulin resistance by inhibition of glucose transport and=or its phosphorylation with a subsequent reduction of glucose oxidation and muscle glycogen synthesis. 17 Recently it has been reported that increased concentrations of plasma FFA induce insulin resistance in animals through inhibition of glucose transport activity; this may be a consequence of decreased IRS-1-associated phosphatidylinositol (PI) 3-kinase activity. 16 However, it has been reported that chronic exposure of islets of Langerhans to FFA leads to an increase in basal insulin secretion that compensates for peripheral insulin resistance in rats. 31 It has also been reported that the high levels of portal FFA may eventually result in an enhancement of hepatic triglyceride synthesis, causing hyperlipidemia and insulin resistance. 32 However, in the present study, as there were no significant differences between the peripheral and portal levels of TNF-a and FFA in ZFR at 6 and 15 weeks of age, we cannot conclude which is more important to produce insulin resistance in the liver.
Our results showed that there was no difference in the TNF-a levels in blood and fat tissues between both groups at 6 weeks of age when insulin resistance was already overt in ZFR. At 15 weeks of age, the TNF-a protein levels in blood and both subcutaneous fat and part of visceral fat tissues were significantly greater in the ZFR group. It has been reported that an elevation of plasma TNF-a levels could occur at a later state of diabetes development secondary to further metabolic alterations. 33, 34 TNF-a is known to be one of the major mediators of insulin resistance. 35 It has been reported that treatment of cultured murine adipocytes with TNF-a was shown to induce serine phosphorylation of IRS-1 and to convert IRS-1 into an inhibitor of the insulin receptor tyrosine kinase activity. 35, 36 Recently, Hube et al reported that a 60 kDa TNF receptor (TNFR) mediates the antiadipogenic effect as well as the down-regulation of glucose transporter-4 (GLUT4) by TNF, thereby leading to long-term inhibition of insulin-stimulated glucose transport. 37 Our results showed that ZFR at 6 weeks of age did not demonstrate a hyperglycemic profile although they had already apparently developed insulin resistance. TNF-a and FFA are secreted from mature adipocytes into the circulation, and could cause progression of insulin resistance, resulting in hyperglycemia. It has been well known that the hyperinsulinemia itself is capable of decreasing insulin-receptor concentration, and thereby reducing tissue sensitivity to insulin, leading to insulin resistance. 38 We demonstrate in the present study that there exists insulin resistance before TNF-a appears to increase in blood and fat tissues in ZFR and that, on the other hand, in this early stage of insulin resistance FFA clearly increases and seems to play an important role in developing insulin resistance in this stage. It is likely that TNF-a and hyperinsulinemia itself accelerate insulin resistance together with FFA in the later stage of insulin resistance leading to diabetes.
